Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference
Globe Newswire•18/11/2026•16:05 ET
0
Key Highlights
- ➤Pulmonx to participate in Piper Sandler healthcare conference fireside discussion December 2, 2026
- ➤Pulmonx will host in-person investor meetings during the conference
- ➤Live and archived webcast will be available on Pulmonx’s investor website
REDWOOD CITY, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside discussion at the Piper Sandler 38(th) Annual Healthcare Conference in New York City on Wednesday, December 2, 2026, at 1:30 PM PT / 4:30 PM ET. The company will also be hosting in-person investor meetings.
A live and archived webcast of the fireside discussion will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.
Get started
Create a free account to read the full story.
